The Diagnostic Imaging CT modality focus page provides information, videos, podcasts, and the latest news about industry product developments, trial results, screening guidelines, and protocol guidance that touch on the use of CT across the healthcare continuum, from various cancer screenings, such as lung and colon, to cardiothoracic imaging, to appendicitis, and more.

Latest News

Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?
Can CT-Based Deep Learning Bolster Prognostic Assessments of Ground-Glass Nodules?

June 19th 2025

Emerging research shows that a multiple time-series deep learning model assessment of CT images provides 20 percent higher sensitivity than a delta radiomic model and 56 percent higher sensitivity than a clinical model for prognostic evaluation of ground-glass nodules.

FDA Clears CT-Based AI Software for Subdural Collections
FDA Clears CT-Based AI Software for Subdural Collections

June 12th 2025

Adjunctive AI Leads to 40 Percent Increase in CT Sensitivity for Lung Metastases in Patients with Colorectal Cancer
Adjunctive AI Leads to 40 Percent Increase in CT Sensitivity for Lung Metastases in Patients with Colorectal Cancer

June 12th 2025

How to Successfully Launch a CCTA Program at Your Hospital or Practice
How to Successfully Launch a CCTA Program at Your Hospital or Practice

June 11th 2025

Study: CT Colonography Screening Offers Up to 16 Percent Higher Reduction of Colorectal Cancer Incidence than Cologuard
Study: CT Colonography Screening Offers Up to 16 Percent Higher Reduction of Colorectal Cancer Incidence than Cologuard

June 10th 2025

Video Interviews
Latest CME Events & Activities

PER Tumor Board®: Applying Recent Advances to Transform the Treatment Paradigm in SCLC—Expert Perspectives on New Approvals and Emerging Strategies

View More

Lung Cancer Tumor Board®: How Do Emerging Data for ICIs, BiTEs, ADCs, and Targeted Strategies Address Unmet Needs in the Therapeutic Continuum for SCLC?

View More

26th Annual International Lung Cancer Congress®

July 25-26, 2025

Register Now!

2025 International Symposium of Gastrointestinal Oncology (ISGIO)

September 12-13, 2025

Register Now!

Lung Cancer Tumor Board: Enhancing Precision Medicine in NSCLC Through Advancements in Molecular Testing and Optimal Therapy Selection

View More

(CME Credit Only) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(MOC and CME Credit) Lung Cancer Tumor Board®: The Pivotal Role of Multimodal Therapy in Leveraging Immunotherapy for Stage I-III NSCLC When the Goal Is Cure

View More

(CME Credit Only) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

(MOC and CME Credit) New Frontiers in Immunotherapy for SCLC: Insights From Latest Clinical Trials and Their Application in Real-World Treatment

View More

43rd Annual CFS®: Innovative Cancer Therapy for Tomorrow™

November 12-14, 2025

Register Now!

20th Annual New York Lung Cancers Symposium®

November 15, 2025

Register Now!

2nd Annual Hawaii Cancer Conference

January 24-25, 2026

Register Now!

23rd Annual Winter Lung Cancer Conference®

January 23-25, 2026

Register Now!

43rd Annual Miami Breast Cancer Conference®

March 5-8, 2026

Register Now!

19th Annual New York GU Cancers Congress™

March 13-14, 2026

Register Now!

Mastering Advances in Managing Unresectable and Metastatic NSCLC—Immunotherapy, Targeted Therapies, and Emerging Strategies

View More

Cases & Conversations™: Expert Perspectives on Leveraging Recent Advances to Transform SCLC Treatment

View More

Community Practice Connections™: Empowering Interventional Radiologists in the Emerging Era of Oncolytic Immunotherapies for Melanoma

View More

(CME Credit) Advancing Outcomes in Limited-Stage Small Cell Lung Cancer: From Evidence to Practice

View More

More News

© 2025 MJH Life Sciences

All rights reserved.